X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15352) 15352
Magazine Article (52) 52
Newsletter (18) 18
Book Chapter (13) 13
Book Review (2) 2
Conference Proceeding (1) 1
Dissertation (1) 1
Journal / eJournal (1) 1
Newspaper Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13060) 13060
methylprednisolone - therapeutic use (10105) 10105
male (7948) 7948
female (7876) 7876
adult (5558) 5558
middle aged (4817) 4817
methylprednisolone (3696) 3696
methylprednisolone - administration & dosage (3087) 3087
treatment outcome (2706) 2706
aged (2592) 2592
anti-inflammatory agents - therapeutic use (2523) 2523
glucocorticoids - therapeutic use (2382) 2382
adolescent (2234) 2234
animals (2083) 2083
immunosuppressive agents - therapeutic use (2067) 2067
drug therapy, combination (1898) 1898
corticosteroids (1866) 1866
child (1749) 1749
surgery (1548) 1548
clinical neurology (1428) 1428
time factors (1243) 1243
therapy (1206) 1206
follow-up studies (1195) 1195
transplantation (1171) 1171
retrospective studies (1165) 1165
immunology (1086) 1086
magnetic resonance imaging (1044) 1044
prednisone - therapeutic use (1042) 1042
medicine, general & internal (1004) 1004
child, preschool (998) 998
rheumatology (918) 918
pediatrics (912) 912
cyclophosphamide - therapeutic use (906) 906
acute disease (888) 888
methylprednisolone - adverse effects (872) 872
steroids (849) 849
azathioprine - therapeutic use (836) 836
care and treatment (809) 809
medicine & public health (807) 807
rats (795) 795
anti-inflammatory agents - administration & dosage (790) 790
adrenal cortex hormones - therapeutic use (787) 787
glucocorticoids - administration & dosage (784) 784
prospective studies (765) 765
prednisolone - therapeutic use (759) 759
neurosciences (756) 756
cyclosporine - therapeutic use (754) 754
children (702) 702
recurrence (698) 698
hematology (695) 695
diagnosis, differential (673) 673
pharmacology & pharmacy (667) 667
methylprednisolone - pharmacology (645) 645
biopsy (643) 643
prognosis (640) 640
disease (637) 637
injections, intravenous (630) 630
dose-response relationship, drug (621) 621
drug therapy (605) 605
methylprednisolone - analogs & derivatives (587) 587
urology & nephrology (586) 586
young adult (585) 585
infant (581) 581
oncology (578) 578
health aspects (573) 573
administration, oral (568) 568
combined modality therapy (562) 562
ophthalmology (562) 562
diagnosis (554) 554
drug administration schedule (554) 554
double-blind method (546) 546
cyclophosphamide (523) 523
glucocorticoids (521) 521
management (514) 514
double-blind (512) 512
immunosuppression (508) 508
risk factors (508) 508
inflammation (496) 496
aged, 80 and over (484) 484
dexamethasone (481) 481
clinical trials as topic (480) 480
kidney transplantation (471) 471
patients (471) 471
immunoglobulins, intravenous - therapeutic use (470) 470
analysis (468) 468
multiple sclerosis (461) 461
tomography, x-ray computed (461) 461
disease models, animal (457) 457
severity of illness index (455) 455
spinal cord injuries - drug therapy (426) 426
research (421) 421
neurology (418) 418
antineoplastic combined chemotherapy protocols - therapeutic use (416) 416
infusions, intravenous (413) 413
neuroprotective agents - therapeutic use (409) 409
kidney transplantation - immunology (404) 404
abridged index medicus (402) 402
transplantation, homologous (401) 401
antilymphocyte serum - therapeutic use (394) 394
immunosuppressive agents - administration & dosage (393) 393
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (13996) 13996
French (365) 365
German (321) 321
Japanese (289) 289
Spanish (253) 253
Italian (155) 155
Chinese (116) 116
Polish (60) 60
Russian (55) 55
Portuguese (47) 47
Danish (24) 24
Hungarian (18) 18
Dutch (17) 17
Czech (16) 16
Norwegian (15) 15
Finnish (11) 11
Swedish (9) 9
Serbian (8) 8
Croatian (7) 7
Turkish (7) 7
Hebrew (6) 6
Romanian (6) 6
Afrikaans (5) 5
Bulgarian (3) 3
Korean (3) 3
Lithuanian (3) 3
Slovak (2) 2
Ukrainian (2) 2
Arabic (1) 1
Belarusian (1) 1
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2017, Volume 2017, Issue 5, p. CD012657
Journal Article
Journal Article
Cochrane library, ISSN 1465-1858, 2018, Volume 2018, Issue 4, p. CD006545
Background Infantile haemangiomas (previously known as strawberry birthmarks) are soft, raised swellings of the skin that occur in 3% to 10% of infants. These... 
Vascular birthmarks e.g infantile haemangiomas | Adrenal Cortex Hormones | Methylprednisolone | Photochemotherapy | topical steroids | lasers | Bleomycin | corticosteroids | Child health | systemic steroids | Propranolol | Hemangioma, Capillary | Prednisolone | Timolol | W. BIRTH MARKS AND DEVELOPMENTAL ABNORMALITIES OF THE SKIN | vincristine | Antineoplastic Agents | Radiotherapy | interferon | Remission Induction | Skin disorders | laser therapy | Randomized Controlled Trials as Topic | intralesional steroids | Skin Neoplasms | imiquimod | Adrenergic beta‐Antagonists | Lasers, Dye | Birthmarks | Skin | Medicine General & Introductory Medical Sciences | W6 Vascular malformations e.g. port‐wine stains | surgery | Antineoplastic Agents [therapeutic use] | Humans | Prednisolone [adverse effects; therapeutic use] | Child, Preschool | Infant | RANDOMIZED CONTROLLED-TRIAL | INTRALESIONAL BLEOMYCIN | MEDICINE, GENERAL & INTERNAL | PULSED DYE-LASER | Radiotherapy [methods] | TOPICAL PROPRANOLOL | Bleomycin [therapeutic use] | INTENSITY FOCUSED ULTRASOUND | TIMOLOL MALEATE 0.5-PERCENT | UNTREATED HEMANGIOMAS | SEQUENTIAL COMBINATION | RISK-FACTORS | Lasers, Dye [therapeutic use] | Remission Induction [methods] | Skin Neoplasms [therapy] | Adrenal Cortex Hormones [adverse effects; therapeutic use] | ORAL PROPRANOLOL | Hemangioma, Capillary [therapy] | Methylprednisolone [adverse effects; therapeutic use] | Photochemotherapy [methods] | Prednisolone - adverse effects | Methylprednisolone - therapeutic use | Skin Neoplasms - therapy | Hemangioma, Capillary - therapy | Photochemotherapy - methods | Timolol - administration & dosage | Methylprednisolone - adverse effects | Antineoplastic Agents - therapeutic use | Lasers, Dye - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Adrenal Cortex Hormones - adverse effects | Bleomycin - therapeutic use | Propranolol - administration & dosage | Radiotherapy - methods | Remission Induction - methods | Prednisolone - therapeutic use | Adrenergic beta-Antagonists - administration & dosage
Journal Article
Cochrane library, ISSN 1465-1858, 2016, Volume 2016, Issue 10, p. CD001446
Background Guillain‐Barré syndrome (GBS) is an acute paralysing disease caused by inflammation of the peripheral nerves, which corticosteroids would be... 
Guillain‐Barre Syndrome | Glucocorticoids | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Neurology | Child health | Guillain‐Barré syndrome | Anti‐Inflammatory Agents | Adrenocorticotropic Hormone | Medicine General & Introductory Medical Sciences | Prednisolone | Corticosteroid treatment | GLOMERULONEPHRITIS | Methylprednisolone [administration & dosage; therapeutic use] | STEROIDS | Humans | Prednisolone [administration & dosage; therapeutic use] | Adrenocorticotropic Hormone [administration & dosage;therapeutic use] | INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY | METHYLPREDNISOLONE | Guillain-Barre Syndrome [drug therapy] | TRIAL | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | PREDNISONE | THERAPY | STANDARD TREATMENT | INTRAVENOUS IMMUNOGLOBULIN | Anti-Inflammatory Agents [administration & dosage;therapeutic use] | Adult | Glucocorticoids [administration & dosage; therapeutic use] | Child | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisolone - administration & dosage | Methylprednisolone - therapeutic use | Adrenocorticotropic Hormone - therapeutic use | Guillain-Barre Syndrome - drug therapy | Adrenocorticotropic Hormone - administration & dosage | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisolone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2014, Volume 127, Issue 10, pp. 931 - 932
Internal Medicine | MEDICINE, GENERAL & INTERNAL | STEVENS-JOHNSON-SYNDROME | Acetaminophen - adverse effects | Dacarbazine - adverse effects | Methylprednisolone - therapeutic use | Humans | Middle Aged | Dexamethasone - adverse effects | Male | Antineoplastic Agents - therapeutic use | Wound Healing | Anticonvulsants - adverse effects | Piracetam - therapeutic use | Stevens-Johnson Syndrome - therapy | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Antiemetics - adverse effects | Oxycodone - therapeutic use | Stevens-Johnson Syndrome - etiology | Anticonvulsants - therapeutic use | gamma-Globulins - therapeutic use | Analgesics, Opioid - therapeutic use | Stevens-Johnson Syndrome - diagnosis | Dexamethasone - therapeutic use | Glioblastoma - pathology | Piracetam - analogs & derivatives | Glioblastoma - complications | Glioblastoma - drug therapy | gamma-Globulins - administration & dosage | Dacarbazine - therapeutic use | Piracetam - adverse effects | Erythema - chemically induced | Analgesics, Opioid - adverse effects | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Erythema - diagnosis | Dacarbazine - analogs & derivatives | Oxycodone - adverse effects | Acetaminophen - therapeutic use | Proton Pump Inhibitors - adverse effects | Omeprazole - therapeutic use | Immunologic Factors - administration & dosage | Omeprazole - adverse effects | Proton Pump Inhibitors - therapeutic use | Piperidines - therapeutic use | Quinazolines - therapeutic use | Piperidines - adverse effects | Quinazolines - adverse effects | Drug Combinations | Immunologic Factors - therapeutic use | Methylprednisolone - administration & dosage | Medicine, Experimental | Toxic epidermal necrolysis | Medical research | Research
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2017, Volume 2017, Issue 1, pp. CD010369 - CD010369
Background Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic progressive or relapsing and remitting disease that usually causes... 
Immunoglobulin treatment | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Chronic inflammatory demyelinating polyradiculopathy | Dexamethasone | Immunosuppressive Agents | Chronic inflammatory demyelinating polyradiculoneuropathy | Adrenal Cortex Hormones | Interferon beta‐1a | Prednisone | Immunosuppressive and immunomodulatory treatment | Plasma Exchange | Methylprednisolone | Peripheral neuropathy | Randomized Controlled Trials as Topic | Plasma exchange treatment | Neurology | Review Literature as Topic | Azathioprine | Methotrexate | Medicine General & Introductory Medical Sciences | Immunoglobulins, Intravenous | Corticosteroid treatment | MEDICINE, GENERAL & INTERNAL | PLASMA-EXCHANGE | NEUROMUSCULAR DISORDERS | MULTIPLE-SCLEROSIS | DOUBLE-BLIND | INTRAVENOUS IMMUNOGLOBULIN TREATMENT | INTEROBSERVER AGREEMENT | RANDOMIZED CONTROLLED-TRIAL | QUALITY-OF-LIFE | METHODOLOGICAL QUALITY | TECHNOLOGY-ASSESSMENT SUBCOMMITTEE | Azathioprine - therapeutic use | Interferon beta-1a - therapeutic use | Methylprednisolone - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating - therapy | Prednisone - therapeutic use | Index Medicus
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2010, Volume 69, Issue 12, pp. 2083 - 2089
Journal Article